1020414-33-8 Usage
Description
1-Naphthalenemethanamine, 7,8-dihydro-α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-, hydrochloride (1:1), (αR)-, commonly known as naphazoline hydrochloride, is a chemical compound that functions as a nasal decongestant and vasoconstrictor. It is utilized to alleviate nasal congestion stemming from allergies, sinusitis, and the common cold by constricting the blood vessels in the nasal passages, thereby reducing swelling and congestion.
Used in Pharmaceutical Industry:
1-Naphthalenemethanamine, 7,8-dihydro-α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-, hydrochloride (1:1), (αR)is used as a nasal decongestant for the relief of nasal congestion caused by allergies, sinusitis, and the common cold. It is effective due to its vasoconstrictor properties, which reduce swelling and congestion in the nasal passages.
Used in Over-the-Counter Medications:
1-Naphthalenemethanamine, 7,8-dihydro-α-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-, hydrochloride (1:1), (αR)is used as an active ingredient in over-the-counter nasal sprays and eye drops. These products are designed to provide quick relief from nasal congestion and associated symptoms, and should be used as directed by a healthcare professional to avoid potential side effects and drug interactions.
Check Digit Verification of cas no
The CAS Registry Mumber 1020414-33-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,0,4,1 and 4 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1020414-33:
(9*1)+(8*0)+(7*2)+(6*0)+(5*4)+(4*1)+(3*4)+(2*3)+(1*3)=68
68 % 10 = 8
So 1020414-33-8 is a valid CAS Registry Number.
1020414-33-8Relevant articles and documents
Dihydronaphthalene compounds, compositions, uses thereof, and methods for synthesis
-
Page/Page column 52-53; figure 1, (2008/06/13)
The present invention relates to novel dihydronaphthalene compounds, compositions, methods for using the same, and processes for preparing the same. The present invention also relates to novel total synthesis approaches for preparing these compounds. In addition, the present invention relates to methods of producing quantities of isomers of these compounds and separating and purifying them using chiral separation techniques. The present invention also relates to methods of producing quantities of a single isometric compound without the need for chiral separation techniques.
